Form 4: 908 Devices Director Michele Leonhart Converts Restricted Stock Units to Common Shares

Michele M. Leonhart, a Director at 908 Devices Inc., acquired 6,485 shares of common stock through the settlement of Restricted Stock Units.

Summary

• Michele M. Leonhart, a Director of 908 Devices Inc., acquired 6,485 shares of common stock on June 25, 2025.
• This acquisition resulted from the settlement of Restricted Stock Units (RSUs) on their scheduled vesting date.
• Each RSU represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
• Following this transaction, Ms. Leonhart beneficially owns 6,485 shares of Common Stock directly.
• She also beneficially owns 12,971 derivative securities (RSUs) directly.
• The RSUs are scheduled to vest in substantially equal annual installments over 3 years following June 25, 2024, contingent on her continued service.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction (RSU vesting) and does not indicate significant positive or negative news about the company's operations or financial performance.

Positives

• Director Michele M. Leonhart's continued accumulation of shares through RSU vesting aligns her interests with shareholders, demonstrating ongoing commitment to the company's performance.

Negatives

• No specific negative information is disclosed in this routine insider transaction report.

Risks

• No specific risks are mentioned in this transaction report, as it pertains to a standard RSU vesting event.

Future Outlook

The remaining 12,971 Restricted Stock Units held by Michele M. Leonhart are scheduled to vest in substantially equal annual installments over the 3 years following June 25, 2024, contingent on her continued service through the applicable vesting dates.

Management Comments

• "Each Restricted Stock Unit ('RSU') represents a contingent right to receive one share of Common Stock, par value $0.001, when vested."
• "This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date."
• "The RSUs become vested in substantially equal annual installments over the 3 years following June 25, 2024, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest."

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically the vesting of Restricted Stock Units (RSUs) for a director. Such transactions are common across publicly traded companies as part of executive and director compensation packages, aligning their interests with long-term shareholder value. It does not provide specific insights into broader industry trends for the analytical instrumentation or life sciences sector in which 908 Devices Inc. operates, beyond the standard compensation practices.

Comparison to Industry Standards

• This document reports a standard RSU vesting event, which is a common form of equity compensation for directors and executives across various industries, including the life sciences and technology sectors.
• Companies like Thermo Fisher Scientific, Agilent Technologies, and Danaher Corporation also utilize similar equity compensation structures to incentivize and retain key personnel.
• The specific number of units vested and remaining is consistent with typical director compensation packages, though direct comparison of specific RSU grants would require detailed compensation reports from comparable companies.

Stakeholder Impact

• Shareholders: The vesting of RSUs aligns the director's interests with shareholders by increasing her direct ownership in the company, potentially fostering long-term commitment.
• Employees: No direct impact on general employees is indicated by this specific filing, as it pertains to director compensation.

Next Steps

• Future vesting of the remaining 12,971 Restricted Stock Units in substantially equal annual installments over the next three years from June 25, 2024, subject to continued service.

Key Dates

Keywords

908 Devices Inc., MASS, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Common Stock, Michele M. Leonhart, Director, Beneficial Ownership